185 related articles for article (PubMed ID: 17979789)
21. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
[TBL] [Abstract][Full Text] [Related]
22. 5-HT radioligands for human brain imaging with PET and SPECT.
Paterson LM; Kornum BR; Nutt DJ; Pike VW; Knudsen GM
Med Res Rev; 2013 Jan; 33(1):54-111. PubMed ID: 21674551
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.
Zeng F; Mun J; Jarkas N; Stehouwer JS; Voll RJ; Tamagnan GD; Howell L; Votaw JR; Kilts CD; Nemeroff CB; Goodman MM
J Med Chem; 2009 Jan; 52(1):62-73. PubMed ID: 19067522
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram.
Schou M; Sóvágó J; Pike VW; Gulyás B; Bøgesø KP; Farde L; Halldin C
Mol Imaging Biol; 2006; 8(1):1-8. PubMed ID: 16322935
[TBL] [Abstract][Full Text] [Related]
26. New Trends and Current Status of Positron-Emission Tomography and Single-Photon-Emission Computerized Tomography Radioligands for Neuronal Serotonin Receptors and Serotonin Transporter.
Hazari PP; Pandey A; Chaturvedi S; Mishra AK
Bioconjug Chem; 2017 Nov; 28(11):2647-2672. PubMed ID: 28767225
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.
Stehouwer JS; Jarkas N; Zeng F; Voll RJ; Williams L; Owens MJ; Votaw JR; Goodman MM
J Med Chem; 2006 Nov; 49(23):6760-7. PubMed ID: 17154506
[TBL] [Abstract][Full Text] [Related]
28. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 (N-fluoroalkyl) labeled 2beta-carbomethoxy-3beta-(4'-(3-furyl)phenyl)tropanes and -nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.
Stehouwer JS; Plisson C; Jarkas N; Zeng F; Voll RJ; Williams L; Martarello L; Votaw JR; Tamagnan G; Goodman MM
J Med Chem; 2005 Nov; 48(22):7080-3. PubMed ID: 16250668
[TBL] [Abstract][Full Text] [Related]
30. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
Psychopharmacology (Berl); 2006 Sep; 188(1):119-27. PubMed ID: 16896954
[TBL] [Abstract][Full Text] [Related]
31. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
[TBL] [Abstract][Full Text] [Related]
32. In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter.
Severance AJ; Milak MS; Kumar JSD; Prabhakaran J; Majo VJ; Simpson NR; Van Heertum RL; Arango V; Mann JJ; Parsey RV
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):688-693. PubMed ID: 17180600
[TBL] [Abstract][Full Text] [Related]
33. The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.
Vanicek T; Spies M; Rami-Mark C; Savli M; Höflich A; Kranz GS; Hahn A; Kutzelnigg A; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Volkow ND; Kasper S; Lanzenberger R
JAMA Psychiatry; 2014 Dec; 71(12):1340-1349. PubMed ID: 25338091
[TBL] [Abstract][Full Text] [Related]
34. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
35. Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.
Li CS; Potenza MN; Lee DE; Planeta B; Gallezot JD; Labaree D; Henry S; Nabulsi N; Sinha R; Ding YS; Carson RE; Neumeister A
Neuroimage; 2014 Feb; 86():306-10. PubMed ID: 24121204
[TBL] [Abstract][Full Text] [Related]
36. Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress.
Logan J; Wang GJ; Telang F; Fowler JS; Alexoff D; Zabroski J; Jayne M; Hubbard B; King P; Carter P; Shea C; Xu Y; Muench L; Schlyer D; Learned-Coughlin S; Cosson V; Volkow ND; Ding YS
Nucl Med Biol; 2007 Aug; 34(6):667-79. PubMed ID: 17707807
[TBL] [Abstract][Full Text] [Related]
37. The norepinephrine transporter (NET) radioligand (S,S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study.
Gulyás B; Brockschnieder D; Nag S; Pavlova E; Kása P; Beliczai Z; Légrádi A; Gulya K; Thiele A; Dyrks T; Halldin C
Neurochem Int; 2010; 56(6-7):789-98. PubMed ID: 20211213
[TBL] [Abstract][Full Text] [Related]
38. New-generation radiotracers for nAChR and NET.
Ding YS; Fowler J
Nucl Med Biol; 2005 Oct; 32(7):707-18. PubMed ID: 16243646
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in silico evaluation of novel compounds for PET-based investigations of the norepinephrine transporter.
Neudorfer C; Seddik A; Shanab K; Jurik A; Rami-Mark C; Holzer W; Ecker G; Mitterhauser M; Wadsak W; Spreitzer H
Molecules; 2015 Jan; 20(1):1712-30. PubMed ID: 25608857
[TBL] [Abstract][Full Text] [Related]
40. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
